drugset / Trial / NCT00924560

A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

NCT00924560

Phase 2 Completed 1361 enrolled Duramed Research
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is being conducted to compare the effects of a 91-day oral contraceptive (OC) to a 28-day OC regimen on bone mineral density (BMD) in adolescent females.

Timeline

Start
2009-06
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 0.1 mg Oral
Subject Levonorgestrel Small molecule 0.15 mg Oral
Subject ethinyl estradiol Small molecule 0.02 mg Oral
Subject ethinyl estradiol Small molecule 0.03 mg Oral

Indications

No indication recorded.